Cargando…
Repurposing Niclosamide for Targeting Pancreatic Cancer by Inhibiting Hh/Gli Non-Canonical Axis of Gsk3β
SIMPLE SUMMARY: The current obstacles for discovering new drugs for cancer therapy have necessitated the development of the alternative strategy of drug repurposing, the identification of new uses for approved or investigational drugs for new therapeutic purposes. Niclosamide (Nic) is a Food and Dru...
Autores principales: | Kaushal, Jyoti B., Bhatia, Rakesh, Kanchan, Ranjana K., Raut, Pratima, Mallapragada, Surya, Ly, Quan P., Batra, Surinder K., Rachagani, Satyanarayana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269055/ https://www.ncbi.nlm.nih.gov/pubmed/34206370 http://dx.doi.org/10.3390/cancers13133105 |
Ejemplares similares
-
Correction: Kaushal et al. Repurposing Niclosamide for Targeting Pancreatic Cancer by Inhibiting Hh/Gli Non-Canonical Axis of Gsk3β. Cancers 2021, 13, 3105
por: Kaushal, Jyoti B., et al.
Publicado: (2021) -
The regulation of Hh/Gli1 signaling cascade involves Gsk3β- mediated mechanism in estrogen-derived endometrial hyperplasia
por: Kaushal, Jyoti Bala, et al.
Publicado: (2017) -
MEDB-87. Transcriptome-driven drug repurposing in group 3 medulloblastoma
por: Doss, David, et al.
Publicado: (2022) -
MDB-40. TRANSCRIPTOME-BASED DRUG REPURPOSING IN GROUP 3 MEDULLOBLASTOMA
por: Doss, David, et al.
Publicado: (2023) -
Repurposing niclosamide for the treatment of neurological disorders
por: Apolloni, Savina, et al.
Publicado: (2023)